FDA Adverse Event Malfunction Summary report: N

2520274-2014-00874

MDR report key: 3650352 · Received February 27, 2014

Report

Report Number
2520274-2014-00874
Event Type
Malfunction
Date Received
February 27, 2014
Report Date
January 31, 2014
Manufacturer
SYNTHES USA
Product Code
HRS
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THIS DEVICE USED FOR TREATMENT AND NOT DIAGNOSIS. THIS REPORT IS ON AN UNKNOWN PLATE, PART AND LOT NUMBERS ARE UNKNOWN. DATE OF EVENT: 2009. ET.AL: CHANG-WUG OHB, JONG-KEON OHC, JOON-WOO KIM, WOO-KIE MIN, IL-HYUNG PARK, HEE-JUNE KIM QIUGEN WANG. WITHOUT A PART NUMBER THE 510K NUMBER CANNOT BE PROVIDED. WITHOUT A LOT NUMBER THE DEVICE HISTORY RECORDS REVIEW COULD NOT BE COMPLETED. THE INVESTIGATION COULD NOT BE COMPLETED; NO CONCLUSION COULD BE DRAWN, AS NO PRODUCT WAS RECEIVED. PLACEHOLDER.

Description of Event or Problem · 1

THIS REPORT IS BEING FILED AFTER THE SUBSEQUENT REVIEW OF THE FOLLOWING JOURNAL ARTICLE: YUSOF, N., ET AL, (2009). PERCUTANEOUS PLATING IN PAEDIATRIC TIBIAL FRACTURES. INJURY, INT. J. CARE INJURED, 40, 1286¿1291. THE AUTHORS REVIEWED 16 PATIENTS (14 BOYS AND 2 GIRLS) WHOSE TIBIAL FRACTURES WERE TREATED WITH PERCUTANEOUS PLATING TECHNIQUE BETWEEN 2000 AND 2007. MEAN AGE AT OPERATION WAS 10 YEARS 9 MONTHS (RANGE: 6-16 YEARS). SYNTHES DEVICES, PROXIMAL LATERAL TIBIAL LOCKING PLATE, OR LIMITED CONTACT DYNAMIC COMPRESSION PLATE OR PROXIMAL LATERAL TIBIAL LOCKING PLATE WERE USED. MEAN FOLLOW UP WAS ONE YEAR EIGHT MONTHS. AN (B)(6) EXPERIENCED LEG LENGTH DISCREPANCY OF 15 MILLIMETERS. THE SYNTHES PLATE WAS NOT SPECIFIED. THE OUTCOME OF THE PATIENT WAS REPORTED AS SATISFACTORY. THE AUTHORS CONCLUDED THAT PERCUTANEOUS PLATING CAN BE SUCCESSFUL WHEN USED FOR TIBIAL FRACTURE CARE IN CHILDREN AND ADOLESCENTS. THIS REPORT IS FOR AN UNKNOWN PLATE. THIS IS REPORT 1 OF 1 FOR COMPLAINT (B)(4).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
122230 HRS SYNTHES USA

Patients

Seq Age Sex Outcome Treatment
1 8 YR